After transfection of glioma cells with si-NC or TNFRSF1A siRNAs, knockdown efficiency of TNFRSF1A siRNA2 was most obvious in both U251 and U87 (Figure 7A). The gene discussed is TNFRSF1A; the disease is central nervous system cancer.